Annual SG&A
$70.45M$32.81M+87.19%
Summary
- Current Value
- As of today, NAMS annual SG&A is $70.45M, up +87.19% on
- Historical Performance
- NAMS annual SG&A is up +1140.90% over the past 3 years, and up +4548.98% over the past 5 years
- All-Time High Comparison
- NAMS annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- NAMS annual SG&A is +261.13% above its 3-year low of $19.51M reached on an earlier date
- Sector Comparison
- NAMS annual SG&A is higher than 78.85% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $70.45M | +87.2% | +1140.9% | +4549.0% | +4549.0% | |
| Quarterly SG&A | $0.00 | -100.0% | 0.0% | 0.0% | 0.0% | |
| TTM SG&A | -$2.46B | -10000.0% | -100.0% | -100.0% | -100.0% | |
| Price | $35.80 | +40.1% | +202.3% | – | – | |
| Annual Operating Expenses | $221.85M | +12.6% | +540.3% | +3317.5% | +3317.5% | |
| Annual Operating Profit | -$176.29M | +3.6% | -408.8% | -2615.6% | -2615.6% | |
| Annual D&A | $113.00K | +130.6% | +2160.0% | +9316.7% | +9316.7% | |
| Annual Revenue | $45.56M | +223.4% | +100.0% | +100.0% | +100.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $70.45M | at high | |
| 5Y | $70.45M | at high | |
| All | $70.45M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $19.51M | N/A | +261.1% |
| 5Y | $1.52M | N/A | +4549.0% |
| All | $1.52M | +4549.0% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $70.45M | +87.2% | |
| $37.63M | +92.9% | |
| $19.51M | +243.6% |
| Year | Value | Change |
|---|---|---|
| $5.68M | +274.6% | |
| $1.52M | - |
FAQ
What is the current annual SG&A of NAMS?
As of today, NAMS annual SG&A is $70.45M
What is 1-year change in NAMS annual SG&A?
NAMS annual SG&A is up +87.19% year-over-year
What is 3-year change in NAMS annual SG&A?
NAMS annual SG&A is up +1140.90% over the past 3 years
How far is NAMS annual SG&A from its all-time high?
NAMS annual SG&A is currently at its all-time high
How does NAMS annual SG&A rank versus sector peers?
NAMS annual SG&A is higher than 78.85% of companies in Healthcare sector
When is NAMS next annual earnings release?
The next annual earnings release for NAMS is on
Quarterly SG&A
$0.00$27.26M-100.00%
Summary
- Current Value
- As of today, NAMS quarterly SG&A is $0.00, down -100.00% on
- Historical Performance
- NAMS quarterly SG&A is down -100.00% year-over-year, and unchanged over the past 3 years
- All-Time High Comparison
- NAMS quarterly SG&A is currently -100.00% below its historical high of $27.26M set on
- 3-Year Low Comparison
- NAMS quarterly SG&A vs 3-year low value is unknown
- Sector Comparison
- NAMS quarterly SG&A is higher than 45.50% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | 0.0% | 0.0% | |
| Annual SG&A | $70.45M | – | +87.2% | +1140.9% | +4549.0% | |
| TTM SG&A | -$2.46B | -2718.4% | -10000.0% | -100.0% | -100.0% | |
| Price | $35.80 | +8.9% | +40.1% | +202.3% | – | |
| Quarterly Operating Expenses | $55.43M | +1.3% | +3.7% | +2316.6% | +10000.0% | |
| Quarterly Operating Profit | -$55.14M | -54.7% | -126.3% | -2304.2% | -10000.0% | |
| Quarterly D&A | $64.00K | +42.2% | +128.6% | – | – | |
| Quarterly Revenue | $348.00K | -98.2% | -98.8% | +100.0% | +100.0% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $27.26M | -100.0% | |
| 3Y | $27.26M | -100.0% | |
| 5Y | $27.26M | -100.0% | |
| All | $27.26M | -100.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of NAMS?
As of today, NAMS quarterly SG&A is $0.00
What is NAMS quarterly SG&A most recent change?
NAMS quarterly SG&A was down -100.00% on September 30, 2025
What is 1-year change in NAMS quarterly SG&A?
NAMS quarterly SG&A is down -100.00% year-over-year
How far is NAMS quarterly SG&A from its all-time high?
NAMS quarterly SG&A is currently -100.00% below its historical high of $27.26M set on June 30, 2025
How does NAMS quarterly SG&A rank versus sector peers?
NAMS quarterly SG&A is higher than 45.50% of companies in Healthcare sector
When is NAMS next earnings release?
The next earnings release for NAMS is on
TTM SG&A
-$2.46B$221.07M-9.88%
Summary
- Current Value
- As of today, NAMS TTM SG&A is -$2.46B, down -9.88% on
- Historical Performance
- NAMS TTM SG&A is down -13458.67% year-over-year, and down -100.00% over the past 3 years
- All-Time High Comparison
- NAMS TTM SG&A is currently -55233.10% below its historical high of $4.46M set on an earlier date
- 3-Year Low Comparison
- NAMS TTM SG&A is at its 3-year low
- Sector Comparison
- NAMS TTM SG&A is higher than 21.55% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$2.46B | -2718.4% | -10000.0% | -100.0% | -100.0% | |
| Annual SG&A | $70.45M | – | +87.2% | +1140.9% | +4549.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | 0.0% | 0.0% | |
| Price | $35.80 | +8.9% | +40.1% | +202.3% | – | |
| TTM Operating Profit | -$202.93M | -17.9% | -54.3% | -3891.9% | -10000.0% | |
| TTM D&A | $212.00K | +20.4% | +241.9% | – | – | |
| TTM Revenue | $35.24M | -44.9% | +7.5% | +100.0% | +100.0% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.89B | N/A | -30.4% |
| 3Y | -$29.19M | N/A | -8327.6% |
| 5Y | $4.46M | N/A | >-9999.0% |
| All | $4.46M | N/A | >-9999.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.46B | N/A | at low |
| 3Y | -$2.46B | N/A | at low |
| 5Y | -$2.46B | N/A | at low |
| All | -$2.46B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of NAMS?
As of today, NAMS TTM SG&A is -$2.46B
What is NAMS TTM SG&A most recent change?
NAMS TTM SG&A was down -9.88% on September 30, 2025
What is 1-year change in NAMS TTM SG&A?
NAMS TTM SG&A is down -13458.67% year-over-year
How does NAMS TTM SG&A rank versus sector peers?
NAMS TTM SG&A is higher than 21.55% of companies in Healthcare sector
When is NAMS next earnings release?
The next earnings release for NAMS is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- NAMS Official Website www.newamsterdampharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1936258/000119312525265796/0001193125-25-265796-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1936258/000095017025027339/0000950170-25-027339-index.htm
- NAMS Profile on Yahoo Finance finance.yahoo.com/quote/NAMS
- NAMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nams